963 / 1851
Additional Evaluations
:
Adequate pulmonary function tests (PFTs) and cardiac function, results from
laboratory tests are normal
Brain MRI: Negative
Molecular Analysis (biopsy of the Lung Tumor):
EGFR
mutation (deletion 19)
Clinical Stage:
T2bN2M0 (IIIA-N2)
Patient was presented and discussed at a multidisciplinary
thoracic tumor board